Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/20/26 19:29 | 5/18/26 | IRD | Health | Drug | Pharmaceutical Preparations | Foundation Fighting Blindness Retinal Degeneration Fund | NC | DH | See Rema | 1 | S | -7,395 | 4.35 | 0 | -1,700 | 3,792 | D | |||||||||||||||
4/27/26 16:28 | 4/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Yerxa Benjamin R | NC | DO | P | 1 | S | -39 | 5.24 | 0 | -7 | 712 | D | |||||||||||||||
4/27/26 16:28 | 4/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Schachle Joseph K | NC | O | COO | 1 | S | -25 | 5.22 | 0 | -5 | 296 | D | |||||||||||||||
4/27/26 16:27 | 4/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Zaremba Rabourn Amy | NC | O | Head of | 1 | S | -9 | 5.20 | 0 | -2 | 189 | D | |||||||||||||||
4/27/26 16:27 | 4/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Magrath George | NC | DO | CEO | 1 | S | -50 | 5.22 | 0 | -10 | 1,741 | D | |||||||||||||||
4/27/26 16:26 | 4/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Jayagopal Ashwath | NC | O | Chief Sc | 1 | S | -39 | 5.19 | 0 | -8 | 509 | D | |||||||||||||||
4/27/26 16:26 | 4/23/26 | IRD | Health | Drug | Pharmaceutical Preparations | Gagnon Robert E. | NC | O | CFO | 1 | S | -41 | 5.18 | 0 | -8 | 592 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |